Nemaura Medical Inc
Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factor… Read more
Nemaura Medical Inc (NMRD) - Total Liabilities
Latest total liabilities as of December 2023: $23.00 Million USD
Based on the latest financial reports, Nemaura Medical Inc (NMRD) has total liabilities worth $23.00 Million USD as of December 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Nemaura Medical Inc - Total Liabilities Trend (2013–2023)
This chart illustrates how Nemaura Medical Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Nemaura Medical Inc Competitors by Total Liabilities
The table below lists competitors of Nemaura Medical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bank of Tianjin Co Ltd
STU:B95
|
Germany | €775.74 Billion |
|
creditshelf Aktiengesellschaft
F:CSQ
|
Germany | €7.66 Million |
Liability Composition Analysis (2013–2023)
This chart breaks down Nemaura Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.19 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 4.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nemaura Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nemaura Medical Inc (2013–2023)
The table below shows the annual total liabilities of Nemaura Medical Inc from 2013 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-03-31 | $26.38 Million | +21.92% |
| 2022-03-31 | $21.64 Million | -19.52% |
| 2021-03-31 | $26.88 Million | +961.39% |
| 2020-03-31 | $2.53 Million | -0.15% |
| 2019-03-31 | $2.54 Million | +18.30% |
| 2018-03-31 | $2.14 Million | +5.36% |
| 2017-03-31 | $2.04 Million | -0.91% |
| 2016-03-31 | $2.05 Million | +12.21% |
| 2015-03-31 | $1.83 Million | +9.23% |
| 2014-03-31 | $1.68 Million | -16.21% |
| 2013-03-31 | $2.00 Million | -- |